AU Patent

AU2016289454B2 — Diaryl macrocycle polymorph

Assigned to Turning Point Therapeutics Inc · Expires 2020-07-09 · 6y expired

What this patent protects

This disclosure relates to polymorphs of (7

USPTO Abstract

This disclosure relates to polymorphs of (7

Drugs covered by this patent

Patent Metadata

Patent number
AU2016289454B2
Jurisdiction
AU
Classification
—
Expires
2020-07-09
Drug substance claim
No
Drug product claim
No
Assignee
Turning Point Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.